HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolomic Profiling of Cardiac Fibrosis and Steatosis in Women With or at Risk for HIV.

AbstractBACKGROUND:
Heart failure is a prevalent disorder whose prognosis remains poor despite advances in treatment. Women with or at risk for HIV may be particularly susceptible, yet the metabolic pathways that promote myocardial disease and heart failure in this context remain incompletely characterized.
METHODS:
To evaluate the metabolomic signatures of cardiac magnetic resonance measured phenotypes, we used available plasma metabolomic measures from participants in the Women's Interagency HIV Study who underwent cardiac magnetic resonance imaging. Our primary outcomes were myocardial extracellular volume fraction (MECV) and intramyocardial triglyceride content (IMTG). We applied partial least squares and identified the top 10 lipid and polar metabolites associated with MECV and IMTG. We used multivariable linear regression to evaluate these metabolites' individual associations with each phenotype.
RESULTS:
The mean age of participants (n = 153) was 53 ± 7, 93% were Black or Hispanic, and 74% were HIV positive. Phenylacetylglutamine, a microbial metabolite, was positively associated with MECV after full adjustment and false discovery rate correction. Three phosphatidylcholine species, N-acetylaspartic acid, and a lysophosphatidylcholine species were inversely associated with IMTG, while prolylglycine, methionine sulfoxide, sphingosine, taurine, and phosphorylcholine were positively associated with this phenotype. We found no evidence of interaction by HIV for the observed associations, but there was effect modification by hepatitis C virus of taurine's and phosphorylcholine's associations with IMTG.
CONCLUSION:
Among women with or at risk for HIV, we related various lipid and polar metabolites to cardiac fibrosis or steatosis, of which phenylacetylglutamine, N-acetylaspartic acid, and prolylglycine are novel. These findings implicate plausible mechanisms that could be targetable for therapeutics.
AuthorsSanyog G Shitole, Mahim Naveed, Zheng Wang, Tao Wang, Yoko Kato, Bharath Ambale-Venkatesh, Robert C Kaplan, Phyllis C Tien, Kathryn Anastos, Jason M Lazar, João A C Lima, Qibin Qi, Jorge R Kizer
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 92 Issue 2 Pg. 162-172 (02 01 2023) ISSN: 1944-7884 [Electronic] United States
PMID36215981 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • Phosphorylcholine
  • Triglycerides
Topics
  • Female
  • Humans
  • Phosphorylcholine
  • HIV Infections (complications)
  • Cardiomyopathies (complications)
  • Heart Failure (complications)
  • Fatty Liver (complications)
  • Fibrosis
  • Triglycerides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: